Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant. (Q50861558)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant. |
scientific article |
Statements
Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant. (English)
1 reference
1 reference
Andy K Hsu
1 reference
Anas Younes
1 reference
Anna Sureda
1 reference
Andreas Engert
1 reference
H Miles Prince
1 reference
Martha Li
1 reference
Paula Savage
1 reference
Roberto Bugarini
1 reference
Denise Williams
1 reference
Margaret Squier
1 reference
David S Ritchie
1 reference
5 August 2013
1 reference
55
1 reference
5
1 reference
1053-1060
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference